Shares of Cipla hit a record high of Rs 997.20 as they rose nearly 2 per cent on the BSE in intra-day trade on Wednesday after the Drugs Controller General of India (DCGI) permitted the firm to import Moderna's Covid Vaccine with emergency use authorisation in India. In the past two days, the scrip has gained 4 per cent.